Abstract
Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.
Original language | English (US) |
---|---|
Pages (from-to) | 269-271 |
Number of pages | 3 |
Journal | Infectious Diseases in Clinical Practice |
Volume | 21 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2013 |
Externally published | Yes |
Keywords
- Ceftaroline
- Osteomyelitis
- Staphylococcus aureus
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases